- Home
- KOSS vs CNTB Comparison
KOSS vs CNTB Comparison
Compare KOSS & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- CNTB
- Stock Information
- Founded
- KOSS 1953
- CNTB 2012
- Country
- KOSS United States
- CNTB United States
- Employees
- KOSS N/A
- CNTB N/A
- Industry
- KOSS Consumer Electronics/Appliances
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- CNTB Health Care
- Exchange
- KOSS Nasdaq
- CNTB Nasdaq
- Market Cap
- KOSS 59.3M
- CNTB 44.2M
- IPO Year
- KOSS N/A
- CNTB 2021
- Fundamental
- Price
- KOSS $5.20
- CNTB N/A
- Analyst Decision
- KOSS
- CNTB Strong Buy
- Analyst Count
- KOSS 0
- CNTB 2
- Target Price
- KOSS N/A
- CNTB $7.50
- AVG Volume (30 Days)
- KOSS 90.9K
- CNTB 103.1K
- Earning Date
- KOSS 08-28-2025
- CNTB 05-15-2025
- Dividend Yield
- KOSS N/A
- CNTB N/A
- EPS Growth
- KOSS N/A
- CNTB N/A
- EPS
- KOSS N/A
- CNTB N/A
- Revenue
- KOSS $12,433,361.00
- CNTB $26,033,000.00
- Revenue This Year
- KOSS N/A
- CNTB N/A
- Revenue Next Year
- KOSS N/A
- CNTB N/A
- P/E Ratio
- KOSS N/A
- CNTB N/A
- Revenue Growth
- KOSS N/A
- CNTB N/A
- 52 Week Low
- KOSS $4.00
- CNTB $0.51
- 52 Week High
- KOSS $18.73
- CNTB $1.60
- Technical
- Relative Strength Index (RSI)
- KOSS 50.45
- CNTB 72.64
- Support Level
- KOSS $4.83
- CNTB $1.02
- Resistance Level
- KOSS $5.10
- CNTB $1.07
- Average True Range (ATR)
- KOSS 0.30
- CNTB 0.09
- MACD
- KOSS 0.01
- CNTB 0.01
- Stochastic Oscillator
- KOSS 53.57
- CNTB 91.19
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.